Dr. Crowe-White is a Registered Dietitian and Associate Professor of Human Nutrition. Her research focuses on redox theory and understanding the interplay between bioactive compounds, redox and inflammatory balance, and clinical outcomes related to obesity, cardiometabolic disease, and aging. Outcomes are investigated at the biochemical and genetic level in human and animal models. The Crowe-White Redox Lab has funding from the National Institutes of Health National Cancer Institute and the Office of Dietary Supplements, the American Heart Association, and the Academy of Nutrition and Dietetics among others. https://kcrowe.people.ua.edu/
Representative Publications
- Variation of Serum Lycopene in Response to 100% Watermelon Juice: an Exploratory Analysis of Genetic Variants in a Randomized Controlled Crossover Study. K.M. Crowe-White, V.S. Voruganti, V. Talevi, T. Dudenbostel, V.A. Nagabooshanam, J.L. Locher, A.C. Ellis. Curr Dev Nutr 4: nzaa102, 2020.
- Systemic and Adipose Tissue Redox Status in Sprague Dawley Rats fed Normal and High Fat Diets Supplemented with Lycopene. *K.E. Senkus, L. Tan, K.M. Crowe-White. J Med Food 24: 370-376, 2021.
- Higher Intake of n-6:n-3 Fatty Acids is Associated with Decreased Cardiometabolic Risk Factors in a Racially Diverse Sample of Children. *K.M. Crowe-White, M.I. Cardel, H.H. Burkhalter, T. Huo, J.R. Fernández. Curr Dev Nutr 2: nzy014, 2018.
- Anti-Apoptotic Effects of Carotenoids in Neurodegeneration. H. Park, M.M. Hayden, S. Bannerman, J. Jansen, K.M. Crowe-White. Molecules 25: 3453, 2020.
- Vitamin A Status and Deposition in Neonatal and Weanling Rats Reared by Mothers Consuming Normal and High Fat Diets with Adequate or Supplemented Vitamin A. *Y. Zhang, K.M. Crowe-White, L. Kong, L. Tan. Nutrients 12: 1460, 2020.
Research Interests
Research in the Crowe-White Redox Lab supports the mission of the National Institutes of Health 2020-2030 Strategic Plan for Nutrition Research to investigate epigenetic influences and genetic variants underlying individual responsiveness to nutrition interventions for the purpose of optimizing treatment effectiveness. This extends directly to drug delivery as nutrition is key to the ABCD of clinical pharmacokinetics specifically the bioavailability of drugs and the tissue distribution.
